• Ashraf Mostafa, Alexandros Briasoulis, Tesfaye Telila, Kevin Belgrave, and Cindy Grines.
• Department of Cardiology, Detroit Medical Center, Wayne State University, Detroit, Michigan.
• Am. J. Cardiol. 2016 Mar 15; 117 (6): 1014-20.

AbstractThe presentation of acute pulmonary thromboembolism (PE) can be highly variable resulting in diagnostic challenges and management difficulties. Current guidelines suggest that therapy must be adjusted based on the severity of PE presentation. Systemic thrombolysis is the standard therapy for acute massive PE; however, systemic thrombolysis carries an estimated 20% risk of major hemorrhage, including a 3% to 5% risk of hemorrhagic stroke. There are data supporting the use of catheter-directed therapy (CDT) in massive and submassive PE, but past studies have limited its use to patients in whom systemic thrombolysis has either failed or was contraindicated. There is a paucity of data comparing the efficacy of CDT compared to systemic thrombolysis in different risk groups. This review will summarize the available data on the techniques and indications and outcomes of CDT for acute PE. Copyright © 2016 Elsevier Inc. All rights reserved.

17 keywords...

hide…